• 1
    Mahfoud F, Himmel F, Ukena C, et al. Treatment strategies for resistant arterial hypertension. Dtsch Arztebl Int. 2011;108:725731.
  • 2
    Himmel F, Gisch S, Franzen K, et al. Improved heart rate dynamics in patients undergoing percutaneous renal denervation. Eur Heart J. 2011;32:431.
  • 3
    Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:12751281.
  • 4
    Esler MD, Krum H, Sobotka PA, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:19031909.
  • 5
    Satyapal KS, Haffejee AA, Singh B, et al. Additional renal arteries: incidence and morphometry. Surg Radiol Anat. 2001;23:3338.
  • 6
    Kem DC, Lyons DF, Wenzl J, et al. Renin-dependent hypertension caused by nonfocal stenotic aberrant renal arteries: proof of a new syndrome. Hypertension. 2005;46:380385.
  • 7
    Marshall AG. Aberrant renal arteries and hypertension. Lancet. 1951;2:701705.
  • 8
    Gupta A, Tello R. Accessory renal arteries are not related to hypertension risk: a review of MR angiography data. Am J Roentgenol. 2004;182:15211524.
  • 9
    Bude RO, Forauer AR, Caoili EM, et al. Is it necessary to study accessory arteries when screening the renal arteries for renovascular hypertension? Radiology. 2003;226:411416.
  • 10
    Glodny B, Cromme S, Wortler K, Winde G. A possible explanation for the frequent concomitance of arterial hypertension and multiple renal arteries. Med Hypotheses. 2001;56:129133.